Older adults with attention deficit-hyperactivity disorder (ADHD) had a significantly higher incidence of car crashes. (JAMA Network Open)

Meanwhile, the estimated prevalence of ADHD in kids 4 years and up held steady — between 10.08% to 10.47% — from 2017 to 2022, according to nationally representative data. (JAMA Network Open)

The FDA released new draft guidance to help sponsors develop treatments for stimulant use disorders.

From January 2019 to August 2022, kids’ use of Mental Health services rose by 22% in the U.S. (JAMA Network Open)

People on maintenance antipsychotic medication for schizophrenia saw no impact on social functioning after 2 years of supported dose reduction compared with those who stayed on therapy. (The Lancet Psychiatry)

More than half of Gen Z’ers struggle with anxiety daily, and a third take medication for it, according to a survey from Harmony Healthcare IT.

Seven California counties started a new mental health court program to help connect people with untreated schizophrenia with housing and medical care — sometimes even without their consent. (AP)

Karuna Therapeutics submitted a new drug application to the FDA for its investigational schizophrenia treatment xanomeline-trospium (KarXT), with supporting data from the EMERGENT clinical program.

Researchers developed an individual-level prediction tool for risk of return to use among people with opioid use disorder by week 3 of treatment. (JAMA Psychiatry)

A former director of an Ohio memory-loss clinic and her physician husband were sentenced to prison for falsely diagnosing patients with Alzheimer’s disease. (AP)

Mood changes weren’t uncommon during the monthly “pill pause” for long-time users of oral contraceptives, especially for women with baseline depression. (JAMA Network Open)

People with schizophrenia may have a genetic predisposition to smoking but a reduced genetic risk of obesity. (American Journal of Psychiatry)